  <!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd"><html xmlns:xalan-nodeset="org.apache.xalan.xslt.extensions.Nodeset" xmlns:java="http://xml.apache.org/xslt/java" xmlns:fo="http://www.w3.org/1999/XSL/Format" xmlns:pto="urn:us:gov:doc:uspto:enterprise" xmlns:bf="http://www.uspto.gov/bf" xmlns:xi="http://www.w3.org/2001/XInclude" xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
   <head>
      <title>2158-</title>
      <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
</head>
      <li><a href="index.html">Manual of Patent Examining Procedure</a></li>
      <li><a href="mpep-2100.html"><span>Chapter 2100</span></a></li>
      <li><span>Section 2158</span></li>  </ul>  </div>
      <div id="yui-main">
         <div class="yui-b">
            <div class="yui-g">  <div xmlns:bf="http://www.uspto.gov/bf" id="article">
               <div>
                  <div xmlns="" class="Section" id="ch2100_d20034_1c351_73">
                     <h1 class="page-title">2158
                        &nbsp;&nbsp;
                        AIA 35 U.S.C. 103 [R-11.2013]
                     </h1>
                     <p id="ch2100_d20034_1c3c1_e"><i>[Editor Note: This MPEP section is
                           <b id="">only applicable</b> to applications subject to examination under the first
                           inventor to file (FITF) provisions of the AIA as set forth in <b><a href="mpep-9015-appx-l.html#al_d1d917_1bef1_2b">35 U.S.C. 100
                                 (note)</a></b>. See <b><a href="s2159.html#ch2100_d20034_1dc34_1dd">MPEP § 2159</a></b> et seq. to determine
                           whether an application is subject to examination under the FITF provisions, and
                           <b><a href="s2141.html#d0e208143">MPEP §
                                 2141</a></b>-<b><a href="s2146.html#d0e213206">MPEP § 2146</a></b> for informaton on
                           <b><a href="mpep-9015-appx-l.html#d0e302450">pre-AIA 35 U.S.C.
                                 103</a></b> and <b><a href="mpep-9015-appx-l.html#al_d1fbe1_19797_b0">AIA 35 U.S.C.
                                 103</a></b>.]</i></p>
                     <p id="ch2100_d20034_1c3c5_2ec"><b><a href="mpep-9015-appx-l.html#al_d1fbe1_19797_b0">AIA 35 U.S.C.
                              103</a></b> continues to set forth the nonobviousness requirement for
                        patentability. There are, however, some important changes from <b><a href="mpep-9015-appx-l.html#d0e302450">pre-AIA 35 U.S.C.
                              103</a></b>.
                     </p>
                     <p id="ch2100_d20034_1c40a_28b">The most significant difference between the
                        <b><a href="mpep-9015-appx-l.html#al_d1fbe1_19797_b0">AIA 35
                              U.S.C. 103</a></b> and <b><a href="mpep-9015-appx-l.html#d0e302455">pre-AIA 35 U.S.C. 103(a)</a></b> is that
                        <b><a href="mpep-9015-appx-l.html#al_d1fbe1_19797_b0">AIA 35 U.S.C.
                              103</a></b> determines obviousness as of the effective filing date of the
                        claimed invention, rather than as of the time that the claimed invention was made. Under
                        pre-AIA examination practice, the Office uses the effective filing date as a proxy for the
                        invention date, unless there is evidence of record to establish an earlier date of
                        invention. Thus, as a practical matter during examination, this distinction between the
                        <b><a href="mpep-9015-appx-l.html#al_d1fbe1_19797_b0">AIA 35 U.S.C.
                              103</a></b> and <b><a href="mpep-9015-appx-l.html#d0e302450">pre-AIA 35 U.S.C. 103</a></b> will result in a
                        difference in practice only when the case under examination is subject to <b><a href="mpep-9015-appx-l.html#d0e302450">pre-AIA 35 U.S.C. 103</a></b>
                        , and there is evidence in the case concerning a date of invention prior to the effective
                        filing date. Such evidence is ordinarily presented by way of an affidavit or declaration
                        under <b><a href="mpep-9020-appx-r.html#aia_d0e323504">37 CFR
                              1.131</a></b>.
                     </p>
                     <p id="ch2100_d20034_1c413_1f0">Next, <b><a href="mpep-9015-appx-l.html#al_d1fbe1_19797_b0">AIA 35 U.S.C.
                              103</a></b> differs from that of <b><a href="mpep-9015-appx-l.html#d0e302450">pre-AIA 35 U.S.C. 103</a></b> in that
                        <b><a href="mpep-9015-appx-l.html#al_d1fbe1_19797_b0">AIA 35 U.S.C.
                              103</a></b> requires consideration of “the differences between the claimed
                        invention and the prior art,” while <b><a href="mpep-9015-appx-l.html#d0e302450">pre-AIA 35 U.S.C. 103</a></b> refers to “the
                        differences between the subject matter sought to be patented and the prior art.” This
                        difference in terminology does not indicate the need for any difference in approach to the
                        question of obviousness. As pointed out by the Federal Circuit, “[t]he term ‘claims' has
                        been used in patent legislation since the Patent Act of 1836 to define the invention that
                        an applicant believes is patentable.” <i>Hoechst-Roussel Pharms., Inc. v.
                           Lehman,</i> 109 F.3d 756, 758, 42 USPQ2d 1220, 1222 (Fed. Cir. 1997) (citing Act
                        of July 4, 1836, ch. 357, § 6, 5 Stat. 117). Furthermore, in <i>Graham v. John
                           Deere,</i> the second of the Supreme Court's factual inquiries (the “Graham
                        factors”) is that the “differences between the prior art and the claims at issue are to be
                        ascertained.” 383 U.S. 1, 17, 148 USPQ 459, 467. Thus, in interpreting <b><a href="mpep-9015-appx-l.html#d0e302450">35 U.S.C. 103</a></b> as
                        enacted in the 1952 Patent Act—language that remained unchanged until enactment of the
                        AIA—the Court equated “the subject matter sought to be patented” with the
                        claims.
                     </p>
                     <p id="ch2100_d20034_1c41c_29d">Further, <b><a href="mpep-9015-appx-l.html#al_d1fbe1_19797_b0">AIA 35 U.S.C.
                              103</a></b> does not contain any provision similar to <b><a href="mpep-9015-appx-l.html#d0e302462">pre-AIA 35 U.S.C.
                              103(b)</a></b>. <b><a href="mpep-9015-appx-l.html#d0e302462">Pre-AIA 35 U.S.C. 103(b)</a></b> is narrowly
                        drawn, applying only to nonobviousness of biotechnological inventions, and even then, only
                        when specifically invoked by the patent applicant. <b><a href="mpep-9015-appx-l.html#d0e302462">Pre-AIA 35 U.S.C. 103(b)</a></b> provides that
                        under certain conditions, “a biotechnological process using or resulting in a composition
                        of matter that is novel under <b><a href="mpep-9015-appx-l.html#d0e302383">section 102</a></b> and nonobvious under
                        subsection [<b><a href="mpep-9015-appx-l.html#d0e302450">103(a)</a></b>] of this section shall be considered nonobvious.” In view of
                        the case law since 1995, the need to invoke <b><a href="mpep-9015-appx-l.html#d0e302462">pre-AIA 35 U.S.C. 103(b)</a></b> has been rare.
                        As stated in <b><a href="s706.html#d0e65889">MPEP §
                              706.02(n)</a></b>, in view of the Federal Circuit's decisions in
                        <i>In re Ochiai,</i> 71 F.3d 1565, 37 USPQ2d 1127 (Fed. Cir. 1995) and
                        <i>In re Brouwer,</i> 77 F.3d 422, 37 USPQ2d 1663 (Fed. Cir. 1996), the need
                        to invoke <b><a href="mpep-9015-appx-l.html#d0e302462">pre-AIA 35
                              U.S.C. 103(b)</a></b> rarely arose. Those cases continue to retain their
                        validity under the AIA.
                     </p>
                     <p id="ch2100_d20034_1c429_24c">Finally, <b><a href="mpep-9015-appx-l.html#al_d1fbe1_19797_b0">AIA 35 U.S.C.
                              103</a></b> eliminates <b><a href="mpep-9015-appx-l.html#d0e302521">pre-AIA 35 U.S.C. 103(c)</a></b>, but
                        corresponding provisions have been introduced in <b><a href="mpep-9015-appx-l.html#al_d1d85b_11e7d_1bf">AIA 35 U.S.C.
                              102(b)(2)(C)</a></b> and <b><a href="mpep-9015-appx-l.html#al_d1d85b_11e8f_148">102(c)</a></b>. <b><a href="mpep-9015-appx-l.html#d0e302521">Pre-AIA 35 U.S.C.
                              103(c)</a></b> applied if subject matter qualified as prior art only under
                        <b><a href="mpep-9015-appx-l.html#d0e302407">pre-AIA 35
                              U.S.C. 102(e)</a></b>, <b><a href="mpep-9015-appx-l.html#d0e302420">(f)</a></b>, and/or <b><a href="mpep-9015-appx-l.html#d0e302424">(g)</a></b>, and only in the
                        context of obviousness under <b><a href="mpep-9015-appx-l.html#d0e302455">pre-AIA 35 U.S.C. 103(a)</a></b>. If subject
                        matter developed by another person was commonly owned with the claimed invention, or if the
                        subject matter was subject to an obligation of assignment to the same person, at the time
                        the claimed invention was made, then <b><a href="mpep-9015-appx-l.html#d0e302455">pre-AIA 35 U.S.C. 103(a)</a></b> did not
                        preclude patentability. Furthermore, under <b><a href="mpep-9015-appx-l.html#d0e302521">pre-AIA 35 U.S.C. 103(c)</a></b>, if a joint
                        research agreement was in place on or before the date that the claimed invention was made,
                        the claimed invention was made as a result of activities undertaken within the scope of the
                        joint research agreement, and the application for patent disclosed or was amended to
                        disclose the names of the parties to the joint research agreement, common ownership or an
                        obligation to assign was deemed to exist. As discussed previously, <b><a href="mpep-9015-appx-l.html#al_d1d85b_11e7d_1bf">AIA 35 U.S.C.
                              102(b)(2)(C)</a></b> and <b><a href="mpep-9015-appx-l.html#al_d1d85b_11e8f_148">102(c)</a></b> expand on this concept. Under
                        the AIA, the common ownership, obligation to assign, or joint research agreement must exist
                        on or before the effective filing date of the claimed invention, rather than on or before
                        the date the invention was made. If the provisions of <b><a href="mpep-9015-appx-l.html#al_d1d85b_11e7d_1bf">AIA 35 U.S.C.
                              102(b)(2)(C)</a></b> are met, a disclosure is not prior art at all, whereas
                        under <b><a href="mpep-9015-appx-l.html#d0e302521">pre-AIA 35 U.S.C.
                              103(c)</a></b> , certain prior art merely was defined as not precluding
                        patentability. Finally, disclosures disqualified as prior art under <b><a href="mpep-9015-appx-l.html#al_d1d85b_11e7d_1bf">AIA 35 U.S.C.
                              102(b)(2)(C)</a></b> and <b><a href="mpep-9015-appx-l.html#al_d1d85b_11e8f_148">102(c)</a></b> may not be applied in either an
                        anticipation or an obviousness rejection. However, such disclosures could be the basis for
                        statutory double patenting or non-statutory (sometimes referred to as obviousness-type)
                        double patenting rejections.
                     </p>
                     <p id="ch2100_d20034_1c45e_2">Generally speaking, and with the exceptions noted
                        herein, pre-AIA notions of obviousness will continue to apply under the AIA.
                        <b><a href="mpep-9015-appx-l.html#al_d1d85b_11e72_2ee">AIA
                              35 U.S.C. 102(a)</a></b> defines what is prior art both for purposes of
                        novelty under <b><a href="mpep-9015-appx-l.html#al_d1fbe1_234ed_52">AIA 35 U.S.C. 102</a></b> as well as for
                        purposes of obviousness under <b><a href="mpep-9015-appx-l.html#al_d1fbe1_19797_b0">AIA 35 U.S.C. 103</a></b>. See
                        <i>Hazeltine Res., Inc. v. Brenner,</i> 382 U.S. 252, 256, 147 USPQ 429, 430
                        (1965) (a previously filed patent application to another pending in the Office, but not
                        patented or published, at the time an application is filed constitutes part of the “prior
                        art” within the meaning of <b><a href="mpep-9015-appx-l.html#d0e302450">35 U.S.C. 103</a></b>). Thus, if a document
                        qualifies as prior art under <b><a href="mpep-9015-appx-l.html#al_d1d85b_11e72_307">AIA 35 U.S.C. 102(a)(1)</a></b> or
                        <b><a href="mpep-9015-appx-l.html#al_d1d85b_11e72_315">(a)(2)</a></b>, and is not subject to an exception under <b><a href="mpep-9015-appx-l.html#al_d1d85b_11e7d_156">AIA 35 U.S.C.
                              102(b)</a></b>, it may be applied for what it describes or teaches to those
                        skilled in the art in a rejection under <b><a href="mpep-9015-appx-l.html#al_d1fbe1_19797_b0">AIA 35 U.S.C. 103</a></b>. This is in
                        accordance with pre-AIA case law indicating that in making determinations under
                        <b><a href="mpep-9015-appx-l.html#d0e302450">35 U.S.C.
                              103</a></b>, “it must be known whether a patent or publication is in the
                        prior art under <b><a href="mpep-9015-appx-l.html#d0e302383">35 U.S.C.
                              102</a></b>.” <i>Panduit Corp. v. Dennison Mfg. Co.,</i> 810 F.2d
                        1561, 1568, 1 USPQ2d 1593, 1597 (Fed. Cir. 1987). However, while a disclosure must enable
                        those skilled in the art to make the invention in order to anticipate under
                        <b><a href="mpep-9015-appx-l.html#d0e302383">35 U.S.C.
                              102</a></b>, a non-enabling disclosure is prior art for all it teaches for
                        purposes of determining obviousness under <b><a href="mpep-9015-appx-l.html#al_d1fbe1_19797_b0">35 U.S.C. 103</a></b> . <i>Symbol Techs.
                           Inc. v. Opticon Inc.,</i> 935 F.2d 1569, 1578, 19 USPQ2d 1241, 1247 (Fed. Cir.
                        1991); <i>Beckman Instruments v. LKB Produkter AB,</i> 892 F.2d 1547, 1551, 13
                        USPQ2d 1301, 1304 (Fed. Cir. 1989) (“Even if a reference discloses an inoperative device,
                        it is prior art for all that it teaches.”). Office personnel should continue to follow
                        guidance for formulating an appropriate rationale to support any conclusion of obviousness.
                        See <b><a href="s2141.html#d0e208143">MPEP §
                              2141</a></b><i>et seq.</i> and the guidance documents available at <b><a href="http://www.uspto.gov/patents/law/exam/ksr%E2%80%94training%E2%80%94materials.jsp" target="_blank">http://www.uspto.gov/patents/law/exam/ksr—training— materials.jsp</a></b>
                        .
                     </p>
                     <p align="right"><a href="#top">[top]</a></p>
                  </div>
               </div>
               <div>
                  <h1 class="page-title">&nbsp;</h1>
               </div>  </div>
            </div>
         </div>
      </div>
      <div class="yui-b">
         <div id="aside">  <div id="rdms-sub-nav-container" xmlns:bf="http://www.uspto.gov/bf">
            <ul id="sub-nav">
               <li xmlns=""><a href="s2101-2102.html">2101-2102-[Reserved]</a></li>
               <li xmlns=""><a href="s2103.html">2103-Patent Examination Process</a></li>
               <li xmlns=""><a href="s2104.html">2104-Patentable Subject Matter</a></li>
               <li xmlns=""><a href="s2105.html">2105-Patentable Subject Matter — Living Subject Matter</a></li>
               <li xmlns=""><a href="s2106.html">2106-Patent Subject Matter Eligibility</a><ul>
                     <li><a href="s2106.html#d0e198001">2106.01-Subject Matter Eligibility Analysis of Process Claims Involving Laws of Nature</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2107.html">2107-Guidelines for Examination of Applications for Compliance with the Utility Requirement</a><ul>
                     <li><a href="s2107.html#d0e198682">2107.01-General Principles Governing Utility Rejections</a></li>
                     <li><a href="s2107.html#d0e199419">2107.02-Procedural Considerations Related to Rejections for Lack of Utility</a></li>
                     <li><a href="s2107.html#d0e200058">2107.03-Special Considerations for Asserted Therapeutic or Pharmacological Utilities</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2108-2110.html">2108-2110-[Reserved]</a></li>
               <li xmlns=""><a href="s2111.html">2111-Claim Interpretation; Broadest Reasonable Interpretation</a><ul>
                     <li><a href="s2111.html#d0e200409">2111.01-Plain Meaning</a></li>
                     <li><a href="s2111.html#d0e200689">2111.02-Effect of Preamble</a></li>
                     <li><a href="s2111.html#d0e200824">2111.03-Transitional Phrases</a></li>
                     <li><a href="s2111.html#d0e201000">2111.04-“Adapted to,” “Adapted for,” “Wherein,” and “Whereby” Clauses</a></li>
                     <li><a href="s2111.html#ch2100_d1b148_1ea0c_2c0">2111.05-Functional and Nonfunctional Descriptive Material</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2112.html">2112-Requirements of Rejection Based on Inherency; Burden of Proof</a><ul>
                     <li><a href="s2112.html#d0e201273">2112.01-Composition, Product, and&nbsp; Apparatus Claims</a></li>
                     <li><a href="s2112.html#d0e201360">2112.02-Process Claims</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2113.html">2113-Product-by-Process Claims</a></li>
               <li xmlns=""><a href="s2114.html">2114-Apparatus and Article Claims — Functional Language</a></li>
               <li xmlns=""><a href="s2115.html">2115-Material or Article Worked Upon by Apparatus</a></li>
               <li xmlns=""><a href="s2116.html">2116-Material Manipulated in Process</a><ul>
                     <li><a href="s2116.html#d0e201660">2116.01-Novel, Unobvious Starting Material or End Product</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2117-2120.html">2117-2120-[Reserved]</a></li>
               <li xmlns=""><a href="s2121.html">2121-Prior Art; General Level of Operability Required to Make a Prima Facie Case</a><ul>
                     <li><a href="s2121.html#d0e201800">2121.01-Use of Prior Art in Rejections Where Operability is in Question</a></li>
                     <li><a href="s2121.html#d0e201868">2121.02-Compounds and Compositions — What Constitutes Enabling Prior Art</a></li>
                     <li><a href="s2121.html#d0e201937">2121.03-Plant Genetics — What Constitutes Enabling Prior Art</a></li>
                     <li><a href="s2121.html#d0e201980">2121.04-Apparatus and Articles — What Constitutes Enabling Prior Art</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2122.html">2122-Discussion of Utility in the Prior Art</a></li>
               <li xmlns=""><a href="s2123.html">2123-Rejection Over Prior Art’s Broad Disclosure Instead of Preferred Embodiments</a></li>
               <li xmlns=""><a href="s2124.html">2124-Exception to the Rule That the Critical Reference Date Must Precede the Filing Date</a><ul>
                     <li><a href="s2124.html#ch2100_d1b13f_20224_b9">2124.01-Tax Strategies Deemed Within the Prior Art</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2125.html">2125-Drawings as Prior Art</a></li>
               <li xmlns=""><a href="s2126.html">2126-Availability of a Document as a “Patent” for Purposes of Rejection Under 35 U.S.C. 102(a) or Pre-AIA 35 U.S.C. 102(a), (b),
                     and (d)</a><ul>
                     <li><a href="s2126.html#d0e202293">2126.01-Date of Availability of a Patent as a Reference</a></li>
                     <li><a href="s2126.html#d0e202334">2126.02-Scope of Reference’s Disclosure Which Can Be Used to Reject Claims When the Reference Is a “Patent” but Not a “Publication”</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2127.html">2127-Domestic and Foreign Patent Applications as Prior Art</a></li>
               <li xmlns=""><a href="s2128.html">2128-“Printed Publications” as Prior Art</a><ul>
                     <li><a href="s2128.html#d0e202706">2128.01-Level of Public Accessibility Required</a></li>
                     <li><a href="s2128.html#d0e202804">2128.02-Date Publication Is Available as a Reference</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2129.html">2129-Admissions as Prior Art</a></li>
               <li xmlns=""><a href="s2130.html">2130-[Reserved]</a></li>
               <li xmlns=""><a href="s2131.html">2131-Anticipation — Application of 35&nbsp;U.S.C. 102</a><ul>
                     <li><a href="s2131.html#d0e203057">2131.01-Multiple Reference 35 U.S.C. 102 Rejections</a></li>
                     <li><a href="s2131.html#d0e203166">2131.02-Genus-Species Situations</a></li>
                     <li><a href="s2131.html#d0e203269">2131.03-Anticipation of Ranges</a></li>
                     <li><a href="s2131.html#d0e203338">2131.04-Secondary Considerations</a></li>
                     <li><a href="s2131.html#d0e203351">2131.05-Nonanalogous or Disparaging Prior Art</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2132.html">2132-Pre-AIA 35 U.S.C. 102(a)</a><ul>
                     <li><a href="s2132.html#d0e203530">2132.01-Publications as Pre-AIA 35 U.S.C. 102(a) Prior Art</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2133.html">2133-Pre-AIA 35 U.S.C. 102(b)</a><ul>
                     <li><a href="s2133.html#d0e203726">2133.01-Rejections of Continuation-In-Part (CIP) Applications</a></li>
                     <li><a href="s2133.html#d0e203739">2133.02-Rejections Based on Publications and Patents</a></li>
                     <li><a href="s2133.html#d0e203781">2133.03-Rejections Based on “Public Use” or “On Sale”</a><ul style="list-style-type: none">
                           <li><a href="s2133.html#d0e203899">2133.03(a)-“Public Use”</a></li>
                           <li><a href="s2133.html#d0e204201">2133.03(b)-“On Sale”</a></li>
                           <li><a href="s2133.html#d0e204494">2133.03(c)-The “Invention”</a></li>
                           <li><a href="s2133.html#d0e204651">2133.03(d)-“In This Country”</a></li>
                           <li><a href="s2133.html#d0e204670">2133.03(e)-Permitted Activity; Experimental Use</a><ul>
                                 <li><a href="s2133.html#d0e204712">2133.03(e)(1)-Commercial Exploitation</a></li>
                                 <li><a href="s2133.html#d0e204884">2133.03(e)(2)-Intent</a></li>
                                 <li><a href="s2133.html#d0e204900">2133.03(e)(3)-“Completeness” of the Invention</a></li>
                                 <li><a href="s2133.html#d0e204981">2133.03(e)(4)-Factors Indicative of an Experimental Purpose</a></li>
                                 <li><a href="s2133.html#d0e205019">2133.03(e)(5)-Experimentation and Degree of Supervision and Control</a></li>
                                 <li><a href="s2133.html#d0e205061">2133.03(e)(6)-Permitted Experimental Activity and Testing</a></li>
                                 <li><a href="s2133.html#d0e205133">2133.03(e)(7)-Activity of an Independent Third Party Inventor</a></li>
                              </ul>
                           </li>
                        </ul>
                     </li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2134.html">2134-Pre-AIA 35 U.S.C. 102(c)</a></li>
               <li xmlns=""><a href="s2135.html">2135-Pre-AIA 35 U.S.C. 102(d)</a><ul>
                     <li><a href="s2135.html#d0e205339">2135.01-The Four Requirements of Pre-AIA 35 U.S.C. 102(d)</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2136.html">2136-Pre-AIA 35 U.S.C. 102(e)</a><ul>
                     <li><a href="s2136.html#d0e205680">2136.01-Status of U.S. Application as a Reference</a></li>
                     <li><a href="s2136.html#d0e205829">2136.02-Content of the Prior Art Available Against the Claims</a></li>
                     <li><a href="s2136.html#d0e205924">2136.03-Critical Reference Date</a></li>
                     <li><a href="s2136.html#d0e206254">2136.04-Different Inventive Entity; Meaning of “By Another”</a></li>
                     <li><a href="s2136.html#d0e206333">2136.05-Overcoming a Rejection Under Pre-AIA 35&nbsp;U.S.C. 102(e)</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2137.html">2137-Pre-AIA 35 U.S.C. 102(f)</a><ul>
                     <li><a href="s2137.html#d0e206713">2137.01-Inventorship</a></li>
                     <li><a href="s2137.html#d0e206972">2137.02-Applicability of Pre-AIA 35 U.S.C. 103(c)</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2138.html">2138-Pre-AIA 35 U.S.C. 102(g)</a><ul>
                     <li><a href="s2138.html#d0e207148">2138.01-Interference Practice</a></li>
                     <li><a href="s2138.html#d0e207398">2138.02-“The Invention Was Made in This Country”</a></li>
                     <li><a href="s2138.html#d0e207478">2138.03-“By Another Who Has Not Abandoned, Suppressed, or Concealed It”</a></li>
                     <li><a href="s2138.html#d0e207607">2138.04-“Conception”</a></li>
                     <li><a href="s2138.html#d0e207753">2138.05-“Reduction to Practice”</a></li>
                     <li><a href="s2138.html#d0e207967">2138.06-“Reasonable Diligence”</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2139-2140.html">2139-2140-[Reserved]</a></li>
               <li xmlns=""><a href="s2141.html">2141-Examination Guidelines for Determining Obviousness Under 35 U.S.C. 103</a><ul>
                     <li><a href="s2141.html#d0e208803">2141.01-Scope and Content of the Prior Art</a><ul style="list-style-type: none">
                           <li><a href="s2141.html#d0e208985">2141.01(a)-Analogous and Nonanalogous Art</a></li>
                        </ul>
                     </li>
                     <li><a href="s2141.html#d0e209106">2141.02-Differences Between Prior Art and Claimed Invention</a></li>
                     <li><a href="s2141.html#d0e209300">2141.03-Level of Ordinary Skill in the Art</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2142.html">2142-Legal Concept of Prima Facie Obviousness</a></li>
               <li xmlns=""><a href="s2143.html">2143-Examples of Basic Requirements of a Prima Facie Case of Obviousness</a><ul>
                     <li><a href="s2143.html#d0e210245">2143.01-Suggestion or Motivation To Modify the References</a></li>
                     <li><a href="s2143.html#d0e210414">2143.02-Reasonable Expectation of Success Is Required</a></li>
                     <li><a href="s2143.html#d0e210501">2143.03-All Claim Limitations Must Be Considered</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2144.html">2144-Supporting a Rejection Under 35 U.S.C. 103</a><ul>
                     <li><a href="s2144.html#d0e210719">2144.01-Implicit Disclosure</a></li>
                     <li><a href="s2144.html#d0e210732">2144.02-Reliance on Scientific Theory</a></li>
                     <li><a href="s2144.html#d0e210752">2144.03-Reliance on Common Knowledge in the Art or “Well Known” Prior Art</a></li>
                     <li><a href="s2144.html#d0e210929">2144.04-Legal Precedent as Source of Supporting Rationale</a></li>
                     <li><a href="s2144.html#d0e211255">2144.05-Obviousness of Ranges</a></li>
                     <li><a href="s2144.html#d0e211480">2144.06-Art Recognized Equivalence for the Same Purpose</a></li>
                     <li><a href="s2144.html#d0e211558">2144.07-Art Recognized Suitability for an Intended Purpose</a></li>
                     <li><a href="s2144.html#d0e211596">2144.08-Obviousness of Species When Prior Art Teaches Genus</a></li>
                     <li><a href="s2144.html#d0e212153">2144.09-Close Structural Similarity Between Chemical Compounds (Homologs, Analogues, Isomers)</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2145.html">2145-Consideration of Applicant’s Rebuttal Arguments</a></li>
               <li xmlns=""><a href="s2146.html">2146-Pre-AIA 35 U.S.C. 103(c)</a></li>
               <li xmlns=""><a href="s2147-2149.html">2147-2149-[Reserved]</a></li>
               <li xmlns=""><a href="s2150.html">2150-Examination Guidelines for 35 U.S.C. 102 and 103 as Amended by the First Inventor To File Provisions of the Leahy-Smith America
                     Invents Act</a></li>
               <li xmlns=""><a href="s2151.html">2151-Overview of the Changes to 35 U.S.C. 102 and 103 in the AIA</a></li>
               <li xmlns=""><a href="s2152.html">2152-Detailed Discussion of AIA 35 U.S.C. 102(a) and (b)</a><ul>
                     <li><a href="s2152.html#ch2100_d20033_1afb3_e6">2152.01-Effective Filing Date of the Claimed Invention</a></li>
                     <li><a href="s2152.html#ch2100_d20033_1d66c_1e5">2152.02-Prior Art Under AIA 35 U.S.C. 102(a)(1) (Patented, Described in a Printed Publication, or in Public Use, on Sale, or Otherwise
                           Available to the Public)</a><ul style="list-style-type: none">
                           <li><a href="s2152.html#ch2100_d20033_1d6c2_3b7">2152.02(a)-Patented</a></li>
                           <li><a href="s2152.html#ch2100_d20033_1da60_2e9">2152.02(b)-Described in a Printed Publication</a></li>
                           <li><a href="s2152.html#ch2100_d20033_1e416_252">2152.02(c)-In Public Use</a></li>
                           <li><a href="s2152.html#ch2100_d20033_2254b_3e0">2152.02(d)-On Sale</a></li>
                           <li><a href="s2152.html#ch2100_d20033_228c0_21c">2152.02(e)-Otherwise Available to the Public</a></li>
                           <li><a href="s2152.html#ch2100_d20033_232ba_27c">2152.02(f)-No Requirement of "By Others"</a></li>
                        </ul>
                     </li>
                     <li><a href="s2152.html#ch2100_d20033_23444_146">2152.03-Admissions</a></li>
                     <li><a href="s2152.html#ch2100_d20033_236db_f9">2152.04-The Meaning of "Disclosure"</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2153.html">2153-Prior Art Exceptions Under 35 U.S.C. 102(b)(1) to AIA 35 U.S.C. 102(a)(1)</a><ul>
                     <li><a href="s2153.html#ch2100_d20033_24caf_cd">2153.01-Prior Art Exception Under AIA 35 U.S.C. 102(b)(1)(A) To AIA 35 U.S.C. 102(a)(1) (Grace Period Inventor Or Inventor-Originated
                           Disclosure Exception)</a><ul style="list-style-type: none">
                           <li><a href="s2153.html#ch2100_d20033_24e66_2ac">2153.01(a)-Grace Period Inventor Disclosure Exception</a></li>
                           <li><a href="s2153.html#ch2100_d20033_256f4_147">2153.01(b)-Grace Period Inventor-Originated Disclosure Exception</a></li>
                        </ul>
                     </li>
                     <li><a href="s2153.html#ch2100_d20033_25935_125">2153.02-Prior Art Exception Under AIA 35 U.S.C. 102(b)(1)(B) to AIA 35 U.S.C. 102(a)(1) (Inventor Or Inventor-Originated Prior Public
                           Disclosure Exception)</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2154.html">2154-Provisions Pertaining to Subject Matter in a U.S. Patent or Application Effectively Filed Before the Effective Filing Date
                     of the Claimed Invention</a><ul>
                     <li><a href="s2154.html#ch2100_d20033_27642_39b">2154.01-Prior Art Under AIA 35 U.S.C. 102(a)(2) “U.S. Patent Documents”</a><ul style="list-style-type: none">
                           <li><a href="s2154.html#ch2100_d20034_11f3b_a0">2154.01(a)-WIPO Published Applications</a></li>
                           <li><a href="s2154.html#ch2100_d20034_12188_300">2154.01(b)-Determining When Subject Matter Was Effectively Filed Under AIA 35 U.S.C. 102(d)</a></li>
                           <li><a href="s2154.html#ch2100_d20034_13884_7c">2154.01(c)-Requirement Of “Names Another Inventor”</a></li>
                        </ul>
                     </li>
                     <li><a href="s2154.html#ch2100_d20034_139ac_31b">2154.02-Prior Art Exceptions Under 35 U.S.C. 102(b)(2) to AIA 35 U.S.C. 102(a)(2)</a><ul style="list-style-type: none">
                           <li><a href="s2154.html#ch2100_d20034_13f89_241">2154.02(a)-Prior Art Exception Under AIA 35 U.S.C. 102(b)(2)(A) to AIA 35 U.S.C. 102(a)(2) (Inventor-Originated Disclosure Exception)</a></li>
                           <li><a href="s2154.html#ch2100_d20034_140df_1a6">2154.02(b)-Prior Art Exception Under AIA 35 U.S.C. 102(b)(2)(B) to AIA 35 U.S.C. 102(a)(2) (Inventor or Inventor-Originated Prior Public
                                 Disclosure Exception)</a></li>
                           <li><a href="s2154.html#ch2100_d20034_145f0_210">2154.02(c)-Prior Art Exception Under AIA 35 U.S.C. 102(b)(2)(C) to AIA 35 U.S.C. 102(a)(2) (Common Ownership or Obligation of Assignment)</a></li>
                        </ul>
                     </li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2155.html">2155-Use of Affidavits or Declarations Under 37 CFR 1.130 To Overcome Prior Art Rejections</a><ul>
                     <li><a href="s2155.html#ch2100_d20034_17271_83">2155.01-Showing That the Disclosure Was Made by the Inventor or a Joint Inventor</a></li>
                     <li><a href="s2155.html#ch2100_d20034_173e3_369">2155.02-Showing That the Subject Matter Disclosed Had Been Previously Publicly Disclosed by the Inventor or a Joint Inventor</a></li>
                     <li><a href="s2155.html#ch2100_d20034_1891a_11">2155.03-Showing That the Disclosure was Made, or That Subject Matter had Been Previously Publicly Disclosed, by Another Who Obtained
                           the Subject Matter Disclosed Directly or Indirectly From the Inventor or a Joint Inventor</a></li>
                     <li><a href="s2155.html#ch2100_d20034_19332_1dd">2155.04-Enablement</a></li>
                     <li><a href="s2155.html#ch2100_d20034_1b102_307">2155.05-Who May File an Affidavit or Declaration Under 37 CFR 1.130</a></li>
                     <li><a href="s2155.html#ch2100_d20034_1b27e_391">2155.06-Situations in Which an Affidavit or Declaration Is Not Available</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2156.html">2156-Joint Research Agreements</a></li>
               <li xmlns=""><a href="s2157.html">2157-Improper Naming of Inventors</a></li>
               <li xmlns=""><a href="s2158.html">2158-AIA 35 U.S.C. 103</a></li>
               <li xmlns=""><a href="s2159.html">2159-Applicability Date Provisions and Determining Whether an Application Is Subject to the First Inventor To File Provisions of
                     the AIA</a><ul>
                     <li><a href="s2159.html#ch2100_d20034_1dc9d_3c4">2159.01-Applications Filed Before March 16, 2013</a></li>
                     <li><a href="s2159.html#ch2100_d20034_1dfd4_279">2159.02-Applications Filed on or After March 16, 2013</a></li>
                     <li><a href="s2159.html#ch2100_d222e3_13adb_2f9">2159.03-Applications Subject to the AIA but Also Containing a Claimed Invention Having an Effective Filing Date Before March 16, 2013</a></li>
                     <li><a href="s2159.html#ch2100_d222e3_140d7_1bb">2159.04-Applicant Statement in Transition Applications Containing a Claimed Invention Having an Effective Filing Date on or After
                           March 16, 2013</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2160.html">2160-[Reserved]</a></li>
               <li xmlns=""><a href="s2161.html">2161-Three Separate Requirements for Specification Under 35 U.S.C. 112(a) or Pre-AIA 35 U.S.C. 112, First Paragraph</a><ul>
                     <li><a href="s2161.html#d0e213447">2161.01-Computer Programming and 35 U.S.C. 112(a) or Pre-AIA 35&nbsp;U.S.C. 112, First Paragraph</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2162.html">2162-Policy Underlying 35 U.S.C. 112(a) or Pre-AIA 35 U.S.C. 112, First Paragraph</a></li>
               <li xmlns=""><a href="s2163.html">2163-Guidelines for the Examination of Patent Applications Under the 35 U.S.C. 112(a) or Pre-AIA 35&nbsp;U.S.C. 112, para. 1, “Written
                     Description” Requirement</a><ul>
                     <li><a href="s2163.html#d0e214533">2163.01-Support for the Claimed Subject Matter in Disclosure</a></li>
                     <li><a href="s2163.html#d0e214553">2163.02-Standard for Determining Compliance With the Written Description Requirement</a></li>
                     <li><a href="s2163.html#d0e214623">2163.03-Typical Circumstances Where Adequate Written Description Issue Arises</a></li>
                     <li><a href="s2163.html#d0e214731">2163.04-Burden on the Examiner with Regard to the Written Description Requirement</a></li>
                     <li><a href="s2163.html#d0e214820">2163.05-Changes to the Scope of Claims</a></li>
                     <li><a href="s2163.html#d0e215023">2163.06-Relationship of Written Description Requirement to New Matter</a></li>
                     <li><a href="s2163.html#d0e215099">2163.07-Amendments to Application Which Are Supported in the Original Description</a><ul style="list-style-type: none">
                           <li><a href="s2163.html#d0e215172">2163.07(a)-Inherent Function, Theory, or Advantage</a></li>
                           <li><a href="s2163.html#d0e215198">2163.07(b)-Incorporation by Reference</a></li>
                        </ul>
                     </li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2164.html">2164-The Enablement Requirement</a><ul>
                     <li><a href="s2164.html#d0e215268">2164.01-Test of Enablement</a><ul style="list-style-type: none">
                           <li><a href="s2164.html#d0e215360">2164.01(a)-Undue Experimentation Factors</a></li>
                           <li><a href="s2164.html#d0e215447">2164.01(b)-How to Make the Claimed Invention</a></li>
                           <li><a href="s2164.html#d0e215491">2164.01(c)-How to Use the Claimed Invention</a></li>
                        </ul>
                     </li>
                     <li><a href="s2164.html#d0e215531">2164.02-Working Example</a></li>
                     <li><a href="s2164.html#d0e215634">2164.03-Relationship of Predictability of the Art and the Enablement Requirement</a></li>
                     <li><a href="s2164.html#d0e215702">2164.04-Burden on the Examiner Under the Enablement Requirement</a></li>
                     <li><a href="s2164.html#d0e215797">2164.05-Determination of Enablement Based on Evidence as a Whole</a><ul style="list-style-type: none">
                           <li><a href="s2164.html#d0e215860">2164.05(a)-Specification Must Be Enabling as of the Filing Date</a></li>
                           <li><a href="s2164.html#d0e215949">2164.05(b)-Specification Must Be Enabling to Persons Skilled in the Art</a></li>
                        </ul>
                     </li>
                     <li><a href="s2164.html#d0e215984">2164.06-Quantity of Experimentation</a><ul style="list-style-type: none">
                           <li><a href="s2164.html#d0e216038">2164.06(a)-Examples of Enablement Issues-Missing Information</a></li>
                           <li><a href="s2164.html#d0e216163">2164.06(b)-Examples of Enablement Issues — Chemical Cases</a></li>
                           <li><a href="s2164.html#d0e216273">2164.06(c)-Examples of Enablement Issues – Computer Programming Cases</a></li>
                        </ul>
                     </li>
                     <li><a href="s2164.html#d0e216498">2164.07-Relationship of Enablement Requirement to Utility Requirement of 35 U.S.C. 101</a></li>
                     <li><a href="s2164.html#d0e216700">2164.08-Enablement Commensurate in Scope With the Claims</a><ul style="list-style-type: none">
                           <li><a href="s2164.html#d0e216855">2164.08(a)-Single Means Claim</a></li>
                           <li><a href="s2164.html#d0e216871">2164.08(b)-Inoperative Subject Matter</a></li>
                           <li><a href="s2164.html#d0e216899">2164.08(c)-Critical Feature Not Claimed</a></li>
                        </ul>
                     </li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2165.html">2165-The Best Mode Requirement</a><ul>
                     <li><a href="s2165.html#d0e216999">2165.01-Considerations Relevant to Best Mode</a></li>
                     <li><a href="s2165.html#d0e217148">2165.02-Best Mode Requirement Compared to Enablement Requirement</a></li>
                     <li><a href="s2165.html#d0e217195">2165.03-Requirements for Rejection for Lack of Best Mode</a></li>
                     <li><a href="s2165.html#d0e217264">2165.04-Examples of Evidence of Concealment</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2166-2170.html">2166-2170-[Reserved]</a></li>
               <li xmlns=""><a href="s2171.html">2171-Two Separate Requirements for Claims Under 35 U.S.C. 112 (b) or Pre-AIA 35 U.S.C. 112, Second Paragraph</a></li>
               <li xmlns=""><a href="s2172.html">2172-Subject Matter Which the Inventor or a Joint Inventor Regards as The Invention</a><ul>
                     <li><a href="s2172.html#d0e217526">2172.01-Unclaimed Essential Matter</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2173.html">2173-Claims Must Particularly Point Out and Distinctly Claim the Invention</a><ul>
                     <li><a href="s2173.html#d0e217578">2173.01-Interpreting the Claims</a></li>
                     <li><a href="s2173.html#d0e217598">2173.02-Determining Whether Claim Language is Definite</a></li>
                     <li><a href="s2173.html#d0e217747">2173.03-Correspondence Between Specification and Claims</a></li>
                     <li><a href="s2173.html#d0e217778">2173.04-Breadth Is Not Indefiniteness</a></li>
                     <li><a href="s2173.html#d0e217809">2173.05-Specific Topics Related to Issues Under 35 U.S.C. 112(b) or Pre-AIA 35 U.S.C. 112, Second Paragraph</a><ul style="list-style-type: none">
                           <li><a href="s2173.html#d0e217839">2173.05(a)-New Terminology</a></li>
                           <li><a href="s2173.html#d0e217939">2173.05(b)-Relative Terminology</a></li>
                           <li><a href="s2173.html#d0e218152">2173.05(c)-Numerical Ranges and Amounts Limitations</a></li>
                           <li><a href="s2173.html#d0e218251">2173.05(d)-Exemplary Claim Language (“for example,” “such as”)</a></li>
                           <li><a href="s2173.html#d0e218320">2173.05(e)-Lack of Antecedent Basis</a></li>
                           <li><a href="s2173.html#d0e218380">2173.05(f)-Reference to Limitations in Another Claim</a></li>
                           <li><a href="s2173.html#d0e218409">2173.05(g)-Functional Limitations</a></li>
                           <li><a href="s2173.html#d0e218467">2173.05(h)-Alternative Limitations</a></li>
                           <li><a href="s2173.html#d0e218588">2173.05(i)-Negative Limitations</a></li>
                           <li><a href="s2173.html#d0e218640">2173.05(j)-Old Combination</a></li>
                           <li><a href="s2173.html#d0e218715">2173.05(k)-Aggregation</a></li>
                           <li><a href="s2173.html#">2173.05(l)-[Reserved]</a></li>
                           <li><a href="s2173.html#d0e218748">2173.05(m)-Prolix</a></li>
                           <li><a href="s2173.html#d0e218755">2173.05(n)-Multiplicity</a></li>
                           <li><a href="s2173.html#d0e218827">2173.05(o)-Double Inclusion</a></li>
                           <li><a href="s2173.html#d0e218855">2173.05(p)-Claim Directed to Product-By- Process or Product and Process</a></li>
                           <li><a href="s2173.html#d0e218952">2173.05(q)-“Use” Claims</a></li>
                           <li><a href="s2173.html#d0e219030">2173.05(r)-Omnibus Claim</a></li>
                           <li><a href="s2173.html#d0e219061">2173.05(s)-Reference to Figures or Tables</a></li>
                           <li><a href="s2173.html#d0e219080">2173.05(t)-Chemical Formula</a></li>
                           <li><a href="s2173.html#d0e219126">2173.05(u)-Trademarks or Trade Names in a Claim</a></li>
                           <li><a href="s2173.html#d0e219164">2173.05(v)-Mere Function of Machine</a></li>
                        </ul>
                     </li>
                     <li><a href="s2173.html#d0e219183">2173.06-Practice Compact Prosecution</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2174.html">2174-Relationship Between the Requirements of 35 U.S.C. 112(a) and (b) or Pre-AIA 35 U.S.C. 112, First and Second Paragraphs</a></li>
               <li xmlns=""><a href="s2175-2180.html">2175-2180-[Reserved]</a></li>
               <li xmlns=""><a href="s2181.html">2181-Identifying and Interpreting a 35 U.S.C. 112(f) or Pre-AIA 35 U.S.C. 112, Sixth Paragraph Limitation</a></li>
               <li xmlns=""><a href="s2182.html">2182-Search and Identification of the Prior Art</a></li>
               <li xmlns=""><a href="s2183.html">2183-Making a Prima Facie Case of Equivalence</a></li>
               <li xmlns=""><a href="s2184.html">2184-Determining Whether an Applicant Has Met the Burden of Proving Nonequivalence After a Prima Facie Case Is Made</a></li>
               <li xmlns=""><a href="s2185.html">2185-Related Issues Under 35 U.S.C. 112(a) or (b) and Pre-AIA 35 U.S.C. 112, First or Second Paragraphs</a></li>
               <li xmlns=""><a href="s2186.html">2186-Relationship to the Doctrine of Equivalents</a></li>
               <li xmlns=""><a href="s2187-2189.html">2187-2189-[Reserved]</a></li>
               <li xmlns=""><a href="s2190.html">2190-Prosecution Laches</a></li>
            </ul>  </div>
         </div>
      </div>  </div>
      <!-- Footer Navigation: /includes/general/footer2.html -->

<!-- Used in: MPEP, CPC -->

<!-- ID = $Id: footer2.html 3354 2013-04-23 18:43:33Z janaki $ -->

<!-- URL = $URL: https://dev-wmb-svn.etc.uspto.gov/repos/live/active_content/trunk/includes/general/footer2.html $ -->





  <div style="text-align:right"> Last Modified: 

     

    03/27/2014 10:10:34 

  </div>

</div>

</div>

<div id="extra-div-1"> <span/> </div>

<div id="extra-div-2"> <span/> </div>

<div id="extra-div-3"> <span/> </div>

<div id="extra-div-4"> <span/> </div>

<div id="extra-div-5"> <span/> </div>

<div id="extra-div-6"> <span/> </div>



<!-- End of footer2.html -->


   </body>
</html>